LSP BioVentures is a global venture capital fund specializing in the healthcare and life sciences sectors, with investments spanning the US, Netherlands, and Germany. The firm typically participates in Series A through Series D rounds, with a focus on innovative companies developing medicines, devices, and tools aimed at preserving health. Their investment sizes vary, with notable rounds ranging from $4 million to over $100 million.
LSP BioVentures boasts a diverse portfolio of nearly 200 companies, including prominent names like argenx, Cardiac Dimensions, and HotSpot Therapeutics. The firm is led by experienced partners who bring a wealth of industry knowledge and connections. Their investment philosophy centers on fostering long-term growth and innovation in the life sciences field. Additionally, LSP BioVentures offers value-added services such as strategic guidance and access to an extensive network of industry experts and co-investors.
LSP Bioventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
